AU7128494A - Gelatinase antagonists used for treating cancer - Google Patents
Gelatinase antagonists used for treating cancerInfo
- Publication number
- AU7128494A AU7128494A AU71284/94A AU7128494A AU7128494A AU 7128494 A AU7128494 A AU 7128494A AU 71284/94 A AU71284/94 A AU 71284/94A AU 7128494 A AU7128494 A AU 7128494A AU 7128494 A AU7128494 A AU 7128494A
- Authority
- AU
- Australia
- Prior art keywords
- gelatinase
- treating cancer
- antagonists used
- antagonists
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000013382 Gelatinases Human genes 0.000 title 1
- 108010026132 Gelatinases Proteins 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939314336A GB9314336D0 (en) | 1993-07-09 | 1993-07-09 | Mutant metalloproteinases |
| GB9314336 | 1993-07-09 | ||
| GB9322774 | 1993-11-04 | ||
| GB939322774A GB9322774D0 (en) | 1993-11-04 | 1993-11-04 | Mutant metalloproteinases |
| PCT/GB1994/001485 WO1995002045A2 (en) | 1993-07-09 | 1994-07-08 | Gelatinase antagonists used for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7128494A true AU7128494A (en) | 1995-02-06 |
Family
ID=26303228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU71284/94A Abandoned AU7128494A (en) | 1993-07-09 | 1994-07-08 | Gelatinase antagonists used for treating cancer |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7128494A (en) |
| WO (1) | WO1995002045A2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0736302A3 (en) * | 1995-03-23 | 1997-06-04 | Stichting Rega V Z W | Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors |
| EP0733369A1 (en) * | 1995-03-23 | 1996-09-25 | Stichting REGA V.Z.W. | Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors |
| WO2001069261A2 (en) * | 2000-03-15 | 2001-09-20 | Oxford Glycosciences (Uk) Ltd. | Proteins, genes and their use for diagnosis and treatment of vascular dementia |
| US7071164B2 (en) | 2001-08-16 | 2006-07-04 | Kimberly-Clark Worldwide, Inc. | Anti-cancer and wound healing compounds |
| US7186693B2 (en) | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
| US6906036B2 (en) * | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| US7148194B2 (en) | 2002-12-30 | 2006-12-12 | Kimberly-Clark Worldwide, Inc. | Method to increase fibronectin |
| US7189700B2 (en) | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4625014A (en) * | 1984-07-10 | 1986-11-25 | Dana-Farber Cancer Institute, Inc. | Cell-delivery agent |
| GB2209526B (en) * | 1987-09-04 | 1992-06-03 | Univ Washington | Dna clone of human type iv collagenase |
| JP2625156B2 (en) * | 1988-06-24 | 1997-07-02 | 市郎 東 | Polypeptide consisting of repeating structure of cell adhesion active core sequence |
-
1994
- 1994-07-08 AU AU71284/94A patent/AU7128494A/en not_active Abandoned
- 1994-07-08 WO PCT/GB1994/001485 patent/WO1995002045A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995002045A3 (en) | 1995-05-19 |
| WO1995002045A2 (en) | 1995-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5975694A (en) | Electrotherapeutic apparatus | |
| AU1072695A (en) | Dressing | |
| AU1272295A (en) | Proinsulin-like compounds | |
| GB9422319D0 (en) | Showerhead | |
| AU7479594A (en) | Chuck | |
| AU7874094A (en) | Retrievable, shielded radiotherapy implant | |
| AU7479694A (en) | Chuck | |
| GB9315595D0 (en) | New compounds | |
| AU5389194A (en) | Wastewater treatment | |
| ZA945545B (en) | Psoriasis treatment | |
| AU7961094A (en) | Picosulphate dosage form | |
| AU6076994A (en) | Grinding apparatus | |
| AU2500192A (en) | Cholecystokinin antagonists useful for treating depression | |
| AU6253094A (en) | Methods for the treatment of osteoporosis | |
| AU6092794A (en) | Oxime-substituted therapeutic compounds | |
| AU7963394A (en) | Mercaptosulfide metalloproteinase inhibitors | |
| AU5261093A (en) | Aminoalkylphenyl compounds | |
| AU1278295A (en) | Wastewater treatment | |
| AU7822591A (en) | Treating an underground formation | |
| AU1480497A (en) | Cancer treatment | |
| AU4584893A (en) | Magnetotherapy apparatus | |
| AU7128494A (en) | Gelatinase antagonists used for treating cancer | |
| AU7018794A (en) | Methods for treating pathologies | |
| AU3292393A (en) | Treating liquids | |
| AU8059894A (en) | Rooting inhibitors |